Green Uptrends

We are outperforming the S & P, join us in our victory.


view:  full / summary

ASYI Our Own Baby Facebook Stock

Posted by AlexaStock on March 25, 2012 at 10:05 AM Comments comments (1)

ASYI a fantastic stock started running last week Monday from .0013 on up to about $0.016, the stock looks to continue movement to the upside. On Friday there was another 8K released after the closing bell. We could see another massive run this week on this stock. With the scheduled IPO of Facebook next month don't be surprise to see this stock trading over $1.00 soon.

 Call Now: 877-661-3839

ASYI is a Social Media stock, that helps you keep up with your friends birthday. ASYI is already intigrated with facebook, with many more features to be added in the near future. This stock is a reverse merger with using it to go public. This company will like a gold mine with so much potential of generating income from sponsors and ads being posted on the site. I ncourage each of you to go to the site and try sending a card to a friend who has a birthday today or anytimis week. It's a fun site for all to use and it's FREE. 


Supplement your Income

Posted by AlexaStock on April 22, 2011 at 9:35 PM Comments comments (0)

Call Now: 866-943-5001


Welcome to PS where it's FREE to join and earn an income ($$$) online while meeting friends, playing games, videos and so much more. Be sure to invite your friends to join as well while you all earn $$$. This is FREE money unlike Facebook which doesn't pay you anything to join. Start earning today, it's FREE. Sincerely, Ingrid Bryant Ingrid has invited you to be a friend on PeopleString. PeopleString is the New Social Portal that allows you to preview all of your favorite Social Networks and Websites on your personal homepage... and then PeopleString shares their revenue with YOU

 Do what you are doing on-line already and get rewarded for it by joining Ingrid 's String today. It's 100% FREE to do. Signup for free now: Regards, Marketing Team PeopleString Corporation See you on the String!

EMLL Gold Stock ready for a RUN @ .0007

Posted by AlexaStock on March 10, 2011 at 11:01 PM Comments comments (0)

Maniel International Inc Enters Into Advance Discussions With Refineries in Hong
Kong SAR, China; Gold Trading Arm to Supply

#article_body p{margin:0 0 15px 0;padding:0}

.articlechart {float:right;width:360px;margin:0 0 10px 20px} .articlechart h2{font-size:14px;text-align:center;margin:0;padding:0} .articlechart p {text-align:center;font-size:12px;padding:3px 0 10px 0;margin:0

EL Maniel Intl (USOTC:EMLL)
Intraday Stock Chart

Today : Thursday 10 March 2011

Click Here for more EL Maniel Intl Charts.

El Maniel International Inc (Pink Sheets:EMLL)
announced today that the Company has entered into advance discussions with a
gold refinery in Hong Kong SAR, China to supply gold from Ghana, Western Africa
"We are very encourage by the level of interest and demand for gold in Hong Kong
and China and we are expecting to formalize our negotiation into long-term
supply contracts by the end of March 2011 with the first shipment as early as
April 2011" states Jamie Khoo, CEO of El Maniel International Inc "We will
capitalize on the gold buyer's license that was granted to us on January 13,
2011 for the export of precious metals and hence, our Gold Trading Division is
expected to generate revenue as early as April 2011 becoming another promising
profit centre."


According to the World Gold Council, China's gold demand is expected to
double in 10 years as more investors accumulate and in the short-term, the
demand for gold will be enough to strain global supplies. China is currently
buying 50% of the world's gold production and this explosive demand is expected
to bring the gold price to record high levels in 2011 as price dips are being
seen as buying opportunity. "We also expect the value of our African assets to
be enhanced by the continued uptrend of gold price which we believe can very
soon chart US$1,600 per Oz," added Jamie Khoo.

El Maniel International Inc (Pink Sheets:EMLL) is a
publicly traded company currently focused on prospecting, developing and
expanding the economic potential of world class mining claims located in Ghana ,
West Africa and the company is committed to shareholder's value creation by
ensuring constant development of current and new resources in the region. For
further information and updates on El Maniel, stay tuned to

1995: The statements contained in this release which are not historical facts
are forward-looking statements that are subject to risks and uncertainties that
could cause actual results to differ materially from those set forth in
or implied by forward-looking statements. These risks and uncertainties include
the Company's entry into new commercial businesses, the risk of obtaining
financing, recruiting and retaining qualified personnel, and other risks
described in the Company's Securities and Exchange Commission filings. The
forward-looking statements in this press release speak only as of the date
hereof, and the Company disclaims any obligation to provide updates, revisions
or amendments to any forward-looking statement to reflect changes in the
Company's expectations or future events.

CONTACT: El Maniel International, Inc
         Investor Relations Contact:
         [email protected]

2011 EMLL DD

Value1 $1,446,055 a/o Mar 09, 2011
Outstanding 2,892,110,000 a/o Sep 30, 2010
Float N/A
Authorized Shares
5,000,000,000 a/o Sep 30, 2010
Par Value 0.001


El Maniel International Inc Enters Into
Advance Discussions With Refineries in Hong Kong SAR, China; Gold Trading Arm to


Termination of Registration of a Class
of Security under Section 13 and 15(d)


El Maniel
International Inc Going for Current Information Tier Status on OTC Market Group


El Maniel International Inc to Commence Alluvial Gold Mining
Operations on the Kumasko Gold Mining Claim Situated in the Central


El Maniel International Inc Enters Into Definitive Agreement
With Agona Rural Bank to Acquire 20% Stakes of the Rural Community


El Maniel International Inc Releases Visuals of the Preliminary
Activities on "Kumasko Project" Under Plot C in the Central Region


El Maniel International Inc. to Acquire 20% Stakes in Agona
Rural Bank Under Its Rural Community Bank Acquisition Program


El Maniel International Inc Completes Geological Mapping and
Geological Survey on Plot A and Plot B of Its Gold Mining Claims


El Maniel International, Inc. Receives Gold Buyer's License for Gold Initiatives Expansion USOTC:EMLL El Maniel International, Inc.

ILNS Ground breaking patent approval

Posted by AlexaStock on March 8, 2011 at 6:31 PM Comments comments (0)

Big player at Wyeth and Pfizer joins ILNS as Alzheimer's pipeline

draws attention

Symbols: ILNS

Sep 10, 2010 (ACCESSWIRE via COMTEX) --

Intellect Neurosciences, Inc.(OTC: ILNS | PowerRating), the micro-cap company whose founder is the inventor and patent holder for the technology platform on which several Alzheimer's drug candidates in late-stage clinical trials (most visibily Bapineuzumab) are based, has announced that it has engaged Dr. Giora Feuerstein as a key consultant to advise the Company regarding its internal preclinical and clinical-stage pipeline.

The news is significant because until earlier this year, Dr. Feuerstein was Assistant Vice President & Head, Discovery Translational Medicine at Pfizer, having previously held these positions at Wyeth Research. In short, Dr. Feuerstein goes from working directly with the leading Alzheimer's drug candidates at those large pharmaceutical companies to working with Intellect Neurosciences on helping develop the company's OXIGON®- a promising potential disease-modifying drug for Alzheimer's disease.

Recently, in an exclusive commentary, Dr. Daniel Chain, Chief Executive Officer of Intellect Neurosciences told BioMedReports that in contrast to many biopharmaceutical companies focused on Alzheimer's disease (AD), Intellect Neurosciences is developing multiple therapeutic approaches and technologies aimed at slowing down, arresting or preventing the disease. His comments came after Lilly (NYSE: LLY) announced that it was ending its large clinical trials of the Alzheimer's drug Semagacestat after disappointing results. "I remain firmly convinced, based on years of research and evidence from genetic, epidiemological, transgenic models and clinical data that the accumulation of soluble amyloid beta in the brain results in a neurodegenerative process that ultimately leads to AD," said Chain. "My opinion is shared by the vast majority of scientists and clinicians involved in Alzheimer's research and I am unaware of any clinical or other data that casts doubt on my strong belief." ILNS's OXIGON® drug is said to have the potential to protect the brain and other tissues against oxidative stress and in addition appears to stabilize the less toxic soluble forms of beta-amyloid preventing aggregation into more toxic forms. As reported previously, it appears that Dr. Chain may have kept the best flavor (of the various anti-beta amyloid monoclonal antibodies which he licensed to Big Pharma) for ILNS and that has made the small company an attractive target on multiple levels. The high late stage failure rate of Alzheimer's drugs has forced even the biggest pharmaceutical players to consider deal structures that allow them to share development risk and seperate industry sources have recently indicated that one global healthcare and pharmaceutical company (some sources are saying Abbott Laboratories) and one large biotech company whose operations are based in Europe, have expressed an interest in partnering with ILNS as it develops its own Alzheimer's drug candidates and newly announced vaccines.


As was reported in July, ILNS was in debt and struggling to survive, but shares have now turned into an attractive rebounding, bottom-priced penny play for investors and volume has gone from nearly zero to millions of shares trading daily.

Dr. Daniel Chain, Chairman and Chief Executive Officer of Intellect, had this to say about Dr. Feuerstein's decision to join ILNS : "We are privileged and absolutely delighted that Dr. Feuerstein has taken an active interest in Intellect Neurosciences. Dr. Feuerstein's breadth and scope of experience in guiding biopharmaceutical research and translational medicine is simply unparalleled in the industry. Dr. Feuerstein is widely credited in relation to the extraordinary cardiovascular and neuroscience pipeline at Wyeth that drove the acquisition by Pfizer last year. His agreement to provide consulting services to Intellect brings a phenomenal set of skills to help the Company in its endeavors to develop innovative and safe disease-modifying drugs for the treatment of Alzheimer's disease and other serious conditions."

Dr. Feuerstein commented: "I am pleased to be able to contribute my knowledge and expertise to help Intellect Neurosciences, which has an exciting pipeline and abundance of innovative ideas to develop new biopharmaceutical products. Dr. Chain impressed me by his critical, objective and balanced scientific assessments that I personally appreciate and like. I am confident that, under this type of leadership, the Company will meet its important objectives focused on the development of innovative drugs that will provide meaningful medical benefits via disease-modifying mechanisms along with maximum safety."

For full details on (ILNS) ILNS. (ILNS) has Short Term PowerRatings at TradingMarkets. Details on (ILNS) Short Term PowerRatings is available at This Link.

Happy Holiday's and help bring joy to others

Posted by AlexaStock on December 22, 2010 at 8:35 AM Comments comments (0)

It is that time of year we all get excited. We waited 12 months to get to this time of year. It's cold and the malls become crowded, loud and at times joyful.

For some it is a time of celebration and for many others it can be a time of sadness. We tend to go on about our lives lost in the excitement of the holiday spirits and forgetting about those that are less fortunate and can only hope to experience a little of the joy and excitement that we experience.

We can make a difference by donating cash or time to those that are in need. Let us not forget about those that are less fortunate, keep them in your prayers and be sure to give as little as $1.00 to help those that are in need. This can be done by donating to one of your local charities or churches within our community.

This is the season of giving and blessings, so lets make a difference by giving and blessing those that maybe less fortunate than us.

On this holiday season let's make a difference by bringing joy to the lives of others who may not be as luck as you and I.

List of charities: javascript:mox();

Work-at-Home Business

Posted by AlexaStock on December 3, 2010 at 6:45 PM Comments comments (0)

There are many work at home projects available to earn an income in your spare time or a full time job. Please find links of work at home jobs and business opportunities available to the general public. There will be different links from time to time to click on and join. For the most part all business opportunities will always be FREE to join unless in certain situations there's an opportunity that's highly irrestable and we elect to add it to our list if it entails a low cost. Start earning an income today.

PREMIUM Streetwear, up to 80% off


Pic Dial




Perri Berri


How to buy Penny Stocks

Posted by AlexaStock on November 6, 2010 at 5:55 PM Comments comments (0)


In order to buy penny stocks we need a small budget first. In today's economy a budget of $1,500 to $2,000 should be enough to get you started. It is obvious that you can't make something from nothing, so stop whining and go out there and start saving in order to invest.


Start looking for companies. You can use any Stock Screener to find companies that have charts available on there. In order for you to be able to analyze those charts you will need to learn Technical Analysis. There are books and guides available online as well as books stores and libraries.


Understand how stock market works, combine that knowledge with technical analysis find stocks that are selling low, buy them and sell them when they become high. It takes lots of practice and experience, that is why it is suggested to start investing fake money first and see how it goes. I wish you all the best investing.




Recent Forum Posts

by AlexaStock over a year ago
by AlexaStock over a year ago
by AlexaStock over a year ago
by AlexaStock over a year ago